Safety and Efficacy Study Of CFI-402411 in Subjects With Advanced Solid Malignancies
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of an investigational drug called CFI-402411
alone and in combination with pembrolizumab and to study its effects in patients with
advanced solid tumors who have progressed following previous therapies.